In the present study, we used NASH patient samples, liver-specific CDAHFD- and MCD-induced AGK-deficient mouse, and biochemical technology to elucidate the roles of AGK in NASH progression and the putative mechanisms. Here, AGK is linked to metabolic dysfunction-associated steatohepatitis.